Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model

References

• Baker-Gabb M, Hunt G, France M (2003) Soft tissue sarcomas and mast cell tumors in dogs; clinical behavior and response to surgery. Aust. Vet. J. 81: 732–738.
   PubMed Web of Science ®Google Scholar
• Berger PD, Engelhardt M, Henß H, Mertelsmann R (2008) Concise Manual of Hematology and Oncology. Springer, Berlin. pp. 87, 737–741.
   Google Scholar
• Bostock DE, Owen LN (1972) Chemotherapy of canine and feline neoplasia. J. Small Anim. Pract. 13: 359–367.
   PubMed Web of Science ®Google Scholar
• Brennan FM, Lewis JJ (2002) Diagnosis and Management of Soft Tissue Sarcoma. Martin Dunitz, London. pp. 92, 150, 169–172, 224.
   Google Scholar
• Buesa JM, Mouridsen HT, van Oosterom AT, Verweij J, Wagener T, Steward W, Poreda A, Vestlev PM, Thomas D, Sylvester R (1991) High dose DTIC in advanced soft tissue sarcomas in the adult. A phase II study of the EORTC soft tissue and bone group. Ann. Oncol. 2: 307–309.
   Google Scholar
• Dobson JM, Samuel S, Milstein H, Rogers K, Wood JLN (2002) Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J. Small Anim. Pract. 43: 240– 246.
   PubMed Web of Science ®Google Scholar
• Frazier SA, Johns SM, Ortega J, Zwingenberger AL, Kent MS, Hammond GM, Rodriguez CO, Steffey MA, Skorupski KA (2012) Outcome in dogs with surgically resected oral fibrosarcoma (1997–2008). Vet. Comp. Oncol. 10: 33–43.
   PubMed Web of Science ®Google Scholar
• Gottlieb JA, Benjamin RS, Baker LH, O’Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez V, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sulliven P, Thigpen T, Bottomley R, Balcerzak S, Moon TE (1976) Role of DTIC (NSC–45388) in the chemotherapy of sarcomas. Cancer Treat. Rep. 60: 199–203.
   PubMedGoogle Scholar
• Grimer R, Judson I, Peake D, Seddon B (2010) Guidelines for the management of soft tissue sarcomas. Sarcoma 2010: 506182.
   PubMedGoogle Scholar
• Hale JH, Goffe AP, Tomlinson BE, Ingham HR, Waller MP, Selkon JB (1965) Studies on tumours developing in hamsters following inoculation of SV–40 virus and BHK–21 cells. Br. J. Exp. Pathol. 46: 598–606.
   PubMedGoogle Scholar
• Havlicek M, Straw RS, Langova V, Dernell WS (2009) Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas. Vet. Comp. Oncol. 7: 122–129.
   PubMed Web of Science ®Google Scholar
• Kažić T (2011) Terapija malignih bolesti. In: Klinička Farmakologija, Farmakoterapija. Integra, Belgrade, Serbia. pp. 285–295.
   Google Scholar
• Marconato L, Comastri S, Lorenzo MR, Abramo F, Bettini G (2007) Postsurgical intra-incisional 5-fluorouracil in dogs with incompletely resected, extremity malignant spindle cell tumors: a pilot study. Vet. Comp. Oncol. 5: 239–249.
   PubMed Web of Science ®Google Scholar
• Marrington AM, Killick DR, Grant IA, Blackwood L (2012) Toxicity associated with epirubicin treatments in a large case series of dogs. Vet. Comp. Oncol. 10: 113–123.
   PubMed Web of Science ®Google Scholar
• National Research Council (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
   Google Scholar
• Payne SE, Rassnick KM, Northrup NC, Kristal O, Chretin JD, Cotter SM, Kintzer P, Frimberg AE, Morrison-Collister KE, Wood CA, Moore AS (2003) Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin. Vet. Comp. Oncol. 1: 171–179.
   PubMedGoogle Scholar
• Ramanathan RK, Cnaan A, Hahn RG, Carbone PP, Hailer DG (2001) Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group–E6282.Ann. Oncol. 12: 1139–1143.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J. 22: 659–661.
   PubMed Web of Science ®Google Scholar
• Sleijfer S, Seynaeve C, Verweij J (2005) Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care. Oncologist 10: 833–841.
   PubMed Web of Science ®Google Scholar
• Smith SA, Zimmerman KL, Moore DM (2010) Hematology of the Syrian (golden) hamster. In: Schalm's Veterinary Hematology, 6th ed., Weiss DJ, Wardrop JK, Eds., Wiley-Blackwell, Ames, IA. pp. 904–909.
   Google Scholar
• Zucali PA, Bertuzzi A, Parra HJS, Campagnoli E, Quagliuolo V, Santoro A (2008) The ‘old drug’ dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas. Invest. New Drugs 26: 175–181.
   PubMed Web of Science ®Google Scholar